A day before he was convicted of securities fraud, “Pharma Bro” Martin Shkreli’s presence was being felt as the Senate passed a bill targeting the price-gouging that made him infamous.

The former pharmaceutical CEO’s move two years ago to raise the price of an anti-malarial drug called Daraprim by 5,000 percent overnight enraged the country. Experts say it also helped shed light on a particular brand of price gouging in the pharmaceutical industry.

Recommended Stories

Eli Lilly opposes using imports to tackle high drug prices

Dems push for subpoena over drug price hike

Pharma CEO: I had ‘moral requirement’ to raise drug price 400 percent